Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NVCA Offshoot to Lobby For VCs and Start-Ups

This article was originally published in Start Up

Executive Summary

The National Venture Capital Association has formed the Medical Innovation and Competitiveness (MedIC) Coalition, to push for more recognition for start-ups developing new devices and therapeutics as well as the venture investors that back them.

You may also be interested in...

Surveys Present Similar Pictures of Plight of VCs

The state of venture capital investing in medical devices and biopharmaceuticals can be examined from different angles and perspectives, but each presents the same troubling image: the two sectors are commanding less and less interest from VCs, according to surveys conducted by Start-Up magazine and the National Venture Capital Association.

Glaukos Holds Lead In Microinvasive Glaucoma Surgery

Glaukos has emerged as the leader in microinvasive glaucoma surgery, a new treatment for the multibillion-dollar market. CEO Tom Burns lays out his vision for his company and for the future of MIGS.

Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts